Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TRHC | Common Stock | Disposed to Issuer | -53.6K | -67.63% | 25.6K | Nov 3, 2023 | Direct | F1 | ||
transaction | TRHC | Common Stock | Disposed to Issuer | -25.6K | -100% | 0 | Nov 3, 2023 | Direct | F2 | ||
transaction | TRHC | Common Stock | Disposed to Issuer | -9.78K | -100% | 0 | Nov 3, 2023 | By Schweitzer Family Trust | F3 |
Pamela Schweitzer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 53,579 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $562,579.50, representing the product obtained by multiplying (x) the number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50). |
F2 | Upon the consummation of the Merger, pursuant to the Merger Agreement, 25,641 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $269,230.50, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50). |
F3 | Upon the consummation of the Merger, pursuant to the Merger Agreement, 9,784 shares of Common Stock were converted into the right to receive a cash payment of $102,732, representing the product obtained by multiplying (x) aggregate number of shares of Common Stock indirectly owned by the reporting person, by (y) the offer price ($10.50). |